Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pulmonary Hypertension, May 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 184 articles:
HTML format


 

Single Articles

  1. HIRAKAWA K, Yamamoto E, Takashio S, Hanatani S, et al
    Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.
    Cardiovasc Interv Ther. 2021 Apr 29. pii: 10.1007/s12928-021-00775.
    PubMed    
    Abstract available

  2. TORRES-CASTRO R, Gimeno-Santos E, Vilaro J, Roque-Figuls M, et al
    Effect of pulmonary hypertension on exercise tolerance in patients with COPD: a prognostic systematic review and meta-analysis.
    Eur Respir Rev. 2021;30.
    PubMed    
    Abstract available

  3. TAKITA Y, Takeda Y, Fujisawa D, Kataoka M, et al
    Depression, anxiety and psychological distress in patients with pulmonary hypertension: a mixed-methods study.
    BMJ Open Respir Res. 2021;8.
    PubMed    
    Abstract available

  4. PRIYA S, Aggarwal T, Ward C, Bathla G, et al
    Radiomics Detection of Pulmonary Hypertension via Texture-Based Assessments of Cardiac MRI: A Machine-Learning Model Comparison-Cardiac MRI Radiomics in Pulmonary Hypertension.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  5. MIGDAL A, Sadel-Wieczorek A, Ryciak E, Mirecka-Rola A, et al
    Children with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension Treated with Pulmonary Vasodilators-The Pediatric Cardiologist Point of View.
    Children (Basel). 2021;8.
    PubMed    
    Abstract available

  6. KWIATKOWSKA J, Meyer-Szary J, Mazurek-Kula A, Zuk M, et al
    The Impact of COVID-19 Pandemic on Children with Pulmonary Arterial Hypertension. Parental Anxiety and Attitudes. Follow-Up Data from the Polish Registry of Pulmonary Hypertension (BNP-PL).
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  7. DWIVEDI K, Sharkey M, Condliffe R, Uthoff JM, et al
    Pulmonary Hypertension in Association with Lung Disease: Quantitative CT and Artificial Intelligence to the Rescue? State-of-the-Art Review.
    Diagnostics (Basel). 2021;11.
    PubMed    
    Abstract available

  8. ZHANG H, Laux A, Stenmark KR, Hu CJ, et al
    Mechanisms Contributing to the Dysregulation of miRNA-124 in Pulmonary Hypertension.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  9. SHARMA M, Levine DJ
    Revisiting a Distinct Entity in Pulmonary Vascular Disease: Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
    Medicina (Kaunas). 2021;57.
    PubMed    
    Abstract available

  10. HUANG S, Li N, Yan D
    Delayed treatment with Endostatin displays a protective role against pulmonary hypertension by targeting VEGF pathway.
    Minerva Med. 2021 Apr 29. pii: S0026-4806.21.07145.
    PubMed    
    Abstract available

  11. SCHWARTZ A, Blank E, Thames M
    A Rare Cause of Pulmonary Hypertension and Right Ventricular Failure: Left Atrial Myxoma.
    CASE (Phila). 2020;5:90-92.
    PubMed    


  12. MARKVARDSEN LK, Sonderskov LD, Wandall-Frostholm C, Pinilla E, et al
    Cystamine Treatment Fails to Prevent the Development of Pulmonary Hypertension in Chronic Hypoxic Rats.
    J Vasc Res. 2021 Apr 28:1-15. doi: 10.1159/000515511.
    PubMed    
    Abstract available

  13. SPIESSHOEFER J, Herkenrath S, Harre K, Kahles F, et al
    Sleep-Disordered Breathing and Nocturnal Hypoxemia in Precapillary Pulmonary Hypertension: Prevalence, Pathophysiological Determinants, and Clinical Consequences.
    Respiration. 2021 Apr 28:1-12. doi: 10.1159/000515602.
    PubMed    
    Abstract available


  14. [2020 Chinese expert-based consensus statement regarding the diagnosis and treatment of connective tissue disease associated pulmonary arterial hypertension].
    Zhonghua Nei Ke Za Zhi. 2021;60:406-420.
    PubMed    
    Abstract available

  15. WANG Q, Li MT, Zeng XF
    [To accumulate clinical evidence and improve the diagnosis and treatment of connective tissue disease associated pulmonary hypertension in China].
    Zhonghua Nei Ke Za Zhi. 2021;60:396-399.
    PubMed    


  16. PEIRONE A, Contreras A, Ferrero Guadagnoli A, Juaneda I, et al
    Bailout procedure in obstructed supracardiac total anomalous pulmonary vein drainage.
    Medicina (B Aires). 2021;81:282-285.
    PubMed    
    Abstract available

  17. ECHAZARRETA DF, Perna ER, Coronel ML, Diez M, et al
    Collaborative registry of pulmonary hypertension in Argentina (RECOPILAR). Final analysis.
    Medicina (B Aires). 2021;81:180-190.
    PubMed    
    Abstract available

  18. NAVANEETHAN SD, Walther CP, Gregg LP, Bansal S, et al
    Mortality, Kidney Failure, and Hospitalization Among Medicare Beneficiaries With CKD and Pulmonary Hypertension.
    Am J Kidney Dis. 2021 Apr 24. pii: S0272-6386(21)00570.
    PubMed    
    Abstract available

  19. CULLEY MK, Zhao J, Tai YY, Tang Y, et al
    Frataxin deficiency promotes endothelial senescence in pulmonary hypertension.
    J Clin Invest. 2021 Apr 27. pii: 136459. doi: 10.1172/JCI136459.
    PubMed    
    Abstract available

  20. XU S, Xu X, Zhang Z, Yan L, et al
    The role of RNA m(6)A methylation in the regulation of postnatal hypoxia-induced pulmonary hypertension.
    Respir Res. 2021;22:121.
    PubMed    
    Abstract available

  21. ARAIN FD, Gilbride VA
    Pulmonary Artery Aneurysm Associated With Severe Pulmonary Hypertension in a Patient Presenting for Double Lung Transplant: Review of a Rare Disorder and Role of Transesophageal Echocardiography.
    Semin Cardiothorac Vasc Anesth. 2021 Apr 25:10892532211007259.
    PubMed    
    Abstract available

  22. WANG AP, Yang F, Tian Y, Su JH, et al
    Pulmonary Artery Smooth Muscle Cell Senescence Promotes the Proliferation of PASMCs by Paracrine IL-6 in Hypoxia-Induced Pulmonary Hypertension.
    Front Physiol. 2021;12:656139.
    PubMed    
    Abstract available

  23. ABSTON E, Hon S, Rodriguez J, Moll M, et al
    Treatment of Pulmonary Hypertension in Patients with Hereditary Hemorrhagic Telangiectasia - a Case Series and Systematic Review.
    Pulm Pharmacol Ther. 2021 Apr 22:102033. doi: 10.1016/j.pupt.2021.102033.
    PubMed    
    Abstract available

  24. TOFOVIC SP, Zhang X, Jones TJ, Petrusevska G, et al
    2-Methoxyestradiol Attenuates the Development and Retards the Progression of Hypoxia-And Alpha-Naphthylthiourea-Induced Pulmonary Hypertension.
    Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2021;42:41-51.
    PubMed    
    Abstract available

  25. SMIRNOVA SL, Roshchevskaya IM
    Depolarization of the Atrial Subepicardium in Rats with Experimentally Induced Pulmonary Hypertension.
    Bull Exp Biol Med. 2021;170:741-743.
    PubMed    
    Abstract available

  26. ROELS E, Fastres A, Merveille AC, Bolen G, et al
    The prevalence of pulmonary hypertension assessed using the pulmonary vein-to-right pulmonary artery ratio and its association with survival in West Highland white terriers with canine idiopathic pulmonary fibrosis.
    BMC Vet Res. 2021;17:171.
    PubMed    
    Abstract available

  27. NIE Y, Sun L, Long W, Lv X, et al
    Clinical importance of the distribution of pulmonary artery embolism in acute pulmonary embolism.
    J Int Med Res. 2021;49:3000605211004769.
    PubMed    
    Abstract available

  28. HABBOUT K, Omura J, Awada C, Bourgeois A, et al
    Implication of EZH2 in the Pro-Proliferative and Apoptosis-Resistant Phenotype of Pulmonary Artery Smooth Muscle Cells in PAH: A Transcriptomic and Proteomic Approach.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  29. LAMBERT V, Ladarre D, Fortas F, Durand P, et al
    Cardiovascular disorders in patients with congenital portosystemic shunts: 23 years of experience in a tertiary referral centre.
    Arch Cardiovasc Dis. 2021;114:221-231.
    PubMed    
    Abstract available

  30. ZHANG S, Wang J, Qi X, Tao X, et al
    Plasminogen activator Inhibitor-2 inhibits pulmonary arterial smooth muscle cell proliferation in pulmonary arterial hypertension via PI3K/Akt and ERK signaling.
    Exp Cell Res. 2021;398:112392.
    PubMed    
    Abstract available

  31. GAMBINI G, Savastano MC, Savastano A, De Vico U, et al
    Ocular Surface Impairment After Coronavirus Disease 2019: A Cohort Study.
    Cornea. 2021;40:477-483.
    PubMed    
    Abstract available

  32. ZIELSKA M, Lewandowski M, Widecka K, Kurzyna M, et al
    Uncommon complication of pulmonary arterial hypertension treatment with the parenteral use of treprostinil.
    Kardiol Pol. 2021;79:79-80.
    PubMed    


  33. MONDEJAR-PARRENO G, Barreira B, Callejo M, Morales-Cano D, et al
    Uncovered Contribution of Kv7 Channels to Pulmonary Vascular Tone in Pulmonary Arterial Hypertension.
    Hypertension. 2020 Aug 24:HYPERTENSIONAHA12015221.
    PubMed    
    Abstract available

  34. XUE C, Senchanthisai S, Sowden M, Pang J, et al
    Endothelial-to-Mesenchymal Transition and Inflammation Play Key Roles in Cyclophilin A-Induced Pulmonary Arterial Hypertension.
    Hypertension. 2020 Aug 24:HYPERTENSIONAHA11914013.
    PubMed    
    Abstract available

  35. GUO X, Lai J, Wang H, Tian Z, et al
    Predictive Value of Pulmonary Arterial Compliance in Systemic Lupus Erythematosus Patients With Pulmonary Arterial Hypertension.
    Hypertension. 2020 Aug 10:HYPERTENSIONAHA12015682.
    PubMed    
    Abstract available

  36. LEI Y, Zhang X, Lin H, Feng Y, et al
    The effects of oral treatment for systemic sclerosis related pulmonary arterial hypertension: A systematic review and meta-analysis.
    Mod Rheumatol. 2021;31:151-161.
    PubMed    
    Abstract available

  37. THEODORAKOPOULOU MP, Pitsiou G, Boutou AK
    Pulmonary hypertension and cardiovascular mortality in end-stage kidney disease: still some way to go before conclusive evidence.
    Int Urol Nephrol. 2021 May 7. pii: 10.1007/s11255-021-02883.
    PubMed    


  38. GONG J, Yang Y, Wang J, Li Y, et al
    Expression of miR-93-5p as a Potential Predictor of the Severity of Chronic Thromboembolic Pulmonary Hypertension.
    Biomed Res Int. 2021;2021:6634417.
    PubMed    
    Abstract available

  39. WATS K, Rodriguez D, Prins KW, Sadiq A, et al
    Association of right ventricular dysfunction and pulmonary hypertension with adverse 30-day outcomes in COVID-19 patients.
    Pulm Circ. 2021;11:20458940211007040.
    PubMed    
    Abstract available

  40. BOUTOU AK, Dipla K, Zafeiridis A, Markopoulou A, et al
    A randomized placebo-control trial of the acute effects of oxygen supplementation on exercise hemodynamics, autonomic modulation, and brain oxygenation in patients with pulmonary hypertension.
    Respir Physiol Neurobiol. 2021;290:103677.
    PubMed    
    Abstract available

  41. AHMED AS, Divani GK, Arora GK
    Differential clubbing with severe pulmonary hypertension.
    QJM. 2021 May 6. pii: 6270929. doi: 10.1093.
    PubMed    


  42. PRCHAL JT, Gordeuk VR
    HIF-2 inhibitor, erythrocytosis, and pulmonary hypertension.
    Blood. 2021;137:2424-2425.
    PubMed    


  43. YAMAMURA A, Nayeem MJ, Sato M
    [Roles of growth factors on vascular remodeling in pulmonary hypertension].
    Nihon Yakurigaku Zasshi. 2021;156:161-165.
    PubMed    
    Abstract available

  44. ABMAN SH
    Pulmonary Hypertension: The Hidden Danger for Newborns.
    Neonatology. 2021 May 5:1-7. doi: 10.1159/000516107.
    PubMed    
    Abstract available

  45. CHOPRA A, Highland KB, Kilb E, Huggins JT, et al
    The Relationship of Pleural and Pericardial Effusion With Pulmonary Hemodynamics in Patients With Pulmonary Hypertension.
    Am J Med Sci. 2021 Jan 9. pii: S0002-9629(21)00003.
    PubMed    
    Abstract available

  46. KOUDSTAAL T, van Uden D, van Hulst JAC, Heukels P, et al
    Plasma markers in pulmonary hypertension subgroups correlate with patient survival.
    Respir Res. 2021;22:137.
    PubMed    
    Abstract available

  47. WANG Y, Li X, Niu W, Chen J, et al
    The alveolar epithelial cells are involved in pulmonary vascular remodeling and constriction of hypoxic pulmonary hypertension.
    Respir Res. 2021;22:134.
    PubMed    
    Abstract available

  48. RAINA A
    When more speaks to less: New insights into arrhythmias in pulmonary hypertension from long term continuous monitoring.
    Int J Cardiol. 2021 May 1. pii: S0167-5273(21)00743.
    PubMed    


  49. STAM K, Clauss S, Taverne YJHJ, Merkus D, et al
    Chronic Thromboembolic Pulmonary Hypertension - What Have We Learned From Large Animal Models.
    Front Cardiovasc Med. 2021;8:574360.
    PubMed    
    Abstract available

  50. KUSIKOVA K, Feichtinger RG, Csillag B, Kalev OK, et al
    Case Report and Review of the Literature: A New and a Recurrent Variant in the VARS2 Gene Are Associated With Isolated Lethal Hypertrophic Cardiomyopathy, Hyperlactatemia, and Pulmonary Hypertension in Early Infancy.
    Front Pediatr. 2021;9:660076.
    PubMed    
    Abstract available

  51. BAKR L, Alnajar S
    A huge right ventricular hydatid cyst related to tricuspid valve causing severe pulmonary hypertension.
    Clin Case Rep. 2020;9:1853-1856.
    PubMed    
    Abstract available

  52. SCHMEISSER A, Rauwolf T, Groscheck T, Fischbach K, et al
    Predictors and prognosis of right ventricular function in pulmonary hypertension due to heart failure with reduced ejection fraction.
    ESC Heart Fail. 2021 May 2. doi: 10.1002/ehf2.13386.
    PubMed    
    Abstract available

  53. MATHIJSSEN H, Huitema MP, Bakker ALM, Smits F, et al
    Clinical Phenotypes of Sarcoidosis-Associated Pulmonary Hypertension.
    Heart Lung Circ. 2021 Apr 28. pii: S1443-9506(21)00406.
    PubMed    
    Abstract available

  54. GODINAS L, Iyer K, Meszaros G, Quarck R, et al
    PH CARE COVID survey: an international patient survey on the care for pulmonary hypertension patients during the early phase of the COVID-19 pandemic.
    Orphanet J Rare Dis. 2021;16:196.
    PubMed    
    Abstract available

  55. RUPERTI-REPILADO FJ, Tobler D, Greutmann M, Bouchardy J, et al
    Risk stratification of adults with congenital heart disease during the COVID-19 pandemic: insights from a multinational survey among European experts.
    Open Heart. 2021;8.
    PubMed    
    Abstract available

  56. GONZAGA-COSTA K, Roque CR, Vasconcelos-Silva AA, Sousa-Brito HL, et al
    The soluble guanylate cyclase stimulator, 1-nitro-2-phenylethane, reverses monocrotaline-induced pulmonary arterial hypertension in rats.
    Life Sci. 2021;275:119334.
    PubMed    
    Abstract available

  57. LIU Y, Li Y, Li J, Zuo X, et al
    Inhibiting miR1 attenuates pulmonary arterial hypertension in rats.
    Mol Med Rep. 2021;23.
    PubMed    
    Abstract available

  58. SAKAO S, Kawakami E, Shoji H, Naito A, et al
    Metabolic remodeling in the right ventricle of rats with severe pulmonary arterial hypertension.
    Mol Med Rep. 2021;23.
    PubMed    
    Abstract available

  59. STADLBAUER C, Golovchenko S, Englert L, Spaeth M, et al
    [Organ Bath Experiments on Human Pulmonary Vessels: Assessment of Drug Efficacy for Treatment of Pulmonary Arterial Hypertension].
    Pneumologie. 2021;75:369-376.
    PubMed    
    Abstract available

  60. VILLAFANE J, Miller JR, Glickstein J, Johnson JN, et al
    Loss of Consciousness in the Young Child.
    Pediatr Cardiol. 2021;42:234-254.
    PubMed    
    Abstract available

  61. YEO Y, Yi ES, Kim JM, Jo EK, et al
    FGF12 (Fibroblast Growth Factor 12) Inhibits Vascular Smooth Muscle Cell Remodeling in Pulmonary Arterial Hypertension.
    Hypertension. 2020 Oct 26:HYPERTENSIONAHA12015068.
    PubMed    
    Abstract available

  62. ZEMSKOVA M, McClain N, Niihori M, Varghese MV, et al
    Necrosis-Released HMGB1 (High Mobility Group Box 1) in the Progressive Pulmonary Arterial Hypertension Associated With Male Sex.
    Hypertension. 2020 Oct 5:HYPERTENSIONAHA12016118.
    PubMed    
    Abstract available

  63. DEROO R, Trepo E, Holvoet T, De Pauw M, et al
    Vasomodulators and liver transplantation for portopulmonary hypertension: evidence from a systematic review and meta-analysis.
    Hepatology. 2020 Feb 4. doi: 10.1002/hep.31164.
    PubMed    
    Abstract available

  64. DESHPANDE S, Suryawanshi P, Holkar S, Singh Y, et al
    Pulmonary hypertension in late onset neonatal sepsis using functional echocardiography: a prospective study.
    J Ultrasound. 2021 May 15. pii: 10.1007/s40477-021-00590.
    PubMed    
    Abstract available

  65. ANGLEITNER P, Schloglhofer T, Wiedemann D, Riebandt J, et al
    The HeartMate 6 and CardioMEMS for Fixed Pulmonary Hypertension.
    ASAIO J. 2021 May 12. pii: 00002480-900000000-98258.
    PubMed    
    Abstract available

  66. LIU C, Chen X, Guo G, Xu X, et al
    Effects of Intermittent Normoxia on Chronic Hypoxic Pulmonary Hypertension and Right Ventricular Hypertrophy in Rats.
    High Alt Med Biol. 2021 May 14. doi: 10.1089/ham.2020.0110.
    PubMed    
    Abstract available

  67. SERRA W
    Reduced Rate of Hospital Admissions for heart failure and pulmonary hypertension during Covid-19 infection. Monocentric experience.
    Acta Biomed. 2021;92:e2021184.
    PubMed    


  68. LIU X, Zhang Y, Fu C, Zhang R, et al
    EnRank: An Ensemble Method to Detect Pulmonary Hypertension Biomarkers Based on Feature Selection and Machine Learning Models.
    Front Genet. 2021;12:636429.
    PubMed    
    Abstract available

  69. HE Z, Zhu S, Zhou K, Jin Y, et al
    Sildenafil for pulmonary hypertension in neonates: An updated systematic review and meta-analysis.
    Pediatr Pulmonol. 2021 May 13. doi: 10.1002/ppul.25444.
    PubMed    
    Abstract available

  70. KAMRAN A, Rafiq N, Khalid A, Amin F, et al
    Effectiveness of oral sildenafil for neonates with persistent pulmonary hypertension of newborn (PPHN): a prospective study in a tertiary care hospital.
    J Matern Fetal Neonatal Med. 2021 May 12:1-7. doi: 10.1080/14767058.2021.1923003
    PubMed    
    Abstract available

  71. HALLIDAY HL, Speer CP
    Sharing Progress in Neonatology (SPIN): Oxygen and Surfactant, Optimal Ventilation, Pulmonary Hypertension, Diagnostic Procedures, and Definition of Bronchopulmonary Dysplasia.
    Neonatology. 2021 May 12:1-4. doi: 10.1159/000516039.
    PubMed    


  72. FARMAKIS I, Vazakidis P, Doundoulakis I, Arvanitaki A, et al
    Haemodynamic effects of PAH-targeted therapies in pulmonary hypertension due to lung disease: A systematic review and meta-analysis.
    Pulm Pharmacol Ther. 2021 May 9:102036. doi: 10.1016/j.pupt.2021.102036.
    PubMed    
    Abstract available

  73. GARG P, Lewis RA, Johns CS, Swift AJ, et al
    Cardiovascular magnetic resonance predicts all-cause mortality in pulmonary hypertension associated with heart failure with preserved ejection fraction.
    Int J Cardiovasc Imaging. 2021 May 12. pii: 10.1007/s10554-021-02279.
    PubMed    
    Abstract available

  74. VANG A, da Silva Goncalves Bos D, Fernandez-Nicolas A, Zhang P, et al
    7 nicotinic acetylcholine receptor mediates right ventricular fibrosis and diastolic dysfunction in pulmonary hypertension.
    JCI Insight. 2021 May 11. pii: 142945. doi: 10.1172/jci.insight.142945.
    PubMed    
    Abstract available

  75. MCCORMACK C, Kehoe B, Hardcastle SJ, McCaffrey N, et al
    Pulmonary hypertension and home-based (PHAHB) exercise intervention: protocol for a feasibility study.
    BMJ Open. 2021;11:e045460.
    PubMed    
    Abstract available

  76. HUANG W, Liu H, Pan Y, Yang H, et al
    Mechanical stretching of the pulmonary vein mediates pulmonary hypertension due to left heart disease by regulating SAC/MAPK pathway and the expression of IL-6 and TNF-alpha.
    J Cardiothorac Surg. 2021;16:127.
    PubMed    
    Abstract available

  77. MCNAIR BD, Schlatter JA, Cook RF, Yusifova M, et al
    Inhibition of mTOR by rapamycin does not improve hypoxic pulmonary hypertension-induced right heart failure in old mice.
    Exp Gerontol. 2021;151:111395.
    PubMed    
    Abstract available

  78. REINERO M, Beghetti M, Tozzi P, Segesser LKV, et al
    Nitric Oxide-cGMP Pathway Modulation in an Experimental Model of Hypoxic Pulmonary Hypertension.
    J Cardiovasc Pharmacol Ther. 2021 May 8:10742484211014162.
    PubMed    
    Abstract available

  79. SHU T, Chen H, Wang L, Wang W, et al
    The Efficacy and Safety of Pulmonary Vasodilators in Pediatric Pulmonary Hypertension (PH): A Systematic Review and Meta-analysis.
    Front Pharmacol. 2021;12:668902.
    PubMed    
    Abstract available

  80. INAO T, Amano M, Hashimoto S, Izumi C, et al
    Rapid Improvement of Severe Pulmonary Hypertension Due to Scoliosis-related Restrictive Ventilatory Disorder.
    Intern Med. 2021 May 7. doi: 10.2169/internalmedicine.6525.
    PubMed    
    Abstract available

  81. KUWANO K, Kosugi K, Fuchikami C, Funaki S, et al
    [Pharmacological characteristics and clinical study results of Selexipag (Uptravi((R)) tablets), a selective prostacyclin receptor agonist].
    Nihon Yakurigaku Zasshi. 2021;156:178-186.
    PubMed    
    Abstract available

  82. RANJAN A, Sundaram V, Taneja M, Dutta S, et al
    Severe neonatal pulmonary artery hypertension rescued with vasopressin.
    BMJ Case Rep. 2021;14.
    PubMed    
    Abstract available

  83. YI D, Liu B, Wang T, Liao Q, et al
    Endothelial Autocrine Signaling through CXCL12/CXCR4/FoxM1 Axis Contributes to Severe Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  84. HUANG Y, Wang ZG, Tang L, Gong SG, et al
    Plasma exosomal miR-596: a novel biomarker predicts survival in patients with idiopathic pulmonary artery hypertension.
    J Int Med Res. 2021;49:3000605211002379.
    PubMed    
    Abstract available

  85. CATTRAN A, Elwing J
    Successful use of intravenous treprostinil as a bridge to pulmonary thromboendarterectomy.
    BMJ Case Rep. 2021;14.
    PubMed    
    Abstract available

  86. OUYANG S, Chen W, Gaofeng Z, Changcheng L, et al
    Cyanidin3Obetaglucoside protects against pulmonary artery hypertension induced by monocrotaline via the TGFbeta1/p38 MAPK/CREB signaling pathway.
    Mol Med Rep. 2021;23.
    PubMed    
    Abstract available

  87. KITAGAWA A, Jacob C, Jordan A, Waddell I, et al
    Inhibition of Glucose-6-Phosphate Dehydrogenase Activity Attenuates Right Ventricle Pressure and Hypertrophy Elicited by VEGFR Inhibitor + Hypoxia.
    J Pharmacol Exp Ther. 2021;377:284-292.
    PubMed    
    Abstract available

  88. AIYENGAR A, Howarth C, Pereira S
    Hypertrophic cardiomyopathy in an extremely preterm infant.
    BMJ Case Rep. 2021;14.
    PubMed    
    Abstract available

  89. XIE X, Li X, Yu F
    Multiple bilateral pulmonary arterial aneurysms with massive thrombosis in inferior vena cava and hepatic vein.
    J Card Surg. 2021;36:1541-1542.
    PubMed    


  90. WANG Z, Jiao G, Huang J, Chen Y, et al
    Management of Eisenmenger syndrome by cardiac defect closure combined bilateral lung transplantation with intraoperative venoarterial ECMO support.
    J Card Surg. 2021;36:1560-1562.
    PubMed    
    Abstract available

  91. HE Y, Xie M, Liu X
    Dyspnoea and diffuse pulmonary nodules in a patient with pulmonary veno-occlusive disease: a case report and literature review.
    J Int Med Res. 2021;49:300060520986689.
    PubMed    
    Abstract available

  92. WANCHAITANAWONG W, Tantiworawit A, Piriyakhuntorn P, Rattanathammethee T, et al
    The association between pre-transfusion hemoglobin levels and thalassemia complications.
    Hematology. 2021;26:1-8.
    PubMed    
    Abstract available

  93. VERMA M, Ojha V, Pandey NN, Saxena A, et al
    An unusual pediatric case of tuberculosis-associated mediastinal fibrosis with concomitant pulmonary arterial and venous occlusion.
    J Card Surg. 2021;36:698-700.
    PubMed    
    Abstract available

  94. ZHOU Q, Peng P, Liu X, Liu J, et al
    Evaluation of maternal and fetal outcomes in pregnancy complicated with pulmonary arterial hypertension.
    Ann Palliat Med. 2021;10:1404-1410.
    PubMed    
    Abstract available

  95. DENG X, Li S, Qiu Q, Jin B, et al
    Where the congenital heart disease meets the pulmonary arterial hypertension, FLNA matters: a case report and literature review.
    BMC Pediatr. 2020;20:504.
    PubMed    
    Abstract available

  96. MULVANEY EP, Reid HM, Bialesova L, Mendes-Ferreira P, et al
    Efficacy of the thromboxane receptor antagonist NTP42 alone, or in combination with sildenafil, in the sugen/hypoxia-induced model of pulmonary arterial hypertension.
    Eur J Pharmacol. 2020 Oct 26:173658. doi: 10.1016/j.ejphar.2020.173658.
    PubMed    
    Abstract available

  97. GUDMUNDSDOTTIR A, Brostrom L, Skiold B, Kallen K, et al
    The type and timing of patent ductus arteriosus treatment was associated with neurodevelopment when extremely preterm infants reached 6.5 years.
    Acta Paediatr. 2020 Jun 30. doi: 10.1111/apa.15452.
    PubMed    
    Abstract available

  98. KOZLOWSKA Z, Owsianska Z, Wroblewska JP, Kaluzna A, et al
    Genotype-phenotype correlation in two Polish neonates with alveolar capillary dysplasia.
    BMC Pediatr. 2020;20:320.
    PubMed    
    Abstract available

  99. ZHU WW, Lv XZ, Li WH
    Hereditary haemorrhagic telangiectasia with heritable pulmonary arterial hypertension.
    Eur Heart J. 2020 May 26. pii: 5846239. doi: 10.1093.
    PubMed    


  100. KATSEFF A, Alhawaj R, Wolin MS
    Redox and Inflammatory Signaling, the Unfolded Protein Response, and the Pathogenesis of Pulmonary Hypertension.
    Adv Exp Med Biol. 2021;1304:333-373.
    PubMed    
    Abstract available

  101. TRUONG L, Zheng YM, Kandhi S, Wang YX, et al
    Overview on Interactive Role of Inflammation, Reactive Oxygen Species, and Calcium Signaling in Asthma, COPD, and Pulmonary Hypertension.
    Adv Exp Med Biol. 2021;1304:147-164.
    PubMed    
    Abstract available

  102. MAIETTA V, Reyes-Garcia J, Yadav VR, Zheng YM, et al
    Cellular and Molecular Processes in Pulmonary Hypertension.
    Adv Exp Med Biol. 2021;1304:21-38.
    PubMed    
    Abstract available

  103. BEHRMANN A, Appleman K, Eghtesady P, Bhattacharya S, et al
    Tricuspid annulus cinching force under pulmonary hypertensive right ventricle conditions: An ex vivo study.
    J Biomech. 2021;123:110488.
    PubMed    
    Abstract available

  104. LI Z, Lv X, Liu Q, Dang D, et al
    Update on the use of sildenafil in neonatal pulmonary hypertension: a narrative review of the history, current administration, and future directions.
    Transl Pediatr. 2021;10:998-1007.
    PubMed    
    Abstract available

  105. LIU C, Sun H, Tang M, Li J, et al
    Ethyl Pyruvate Alleviates Pulmonary Hypertension through the Suppression of Pulmonary Artery Smooth Muscle Cell Proliferation via the High Mobility Group Protein B1/Receptor for Advanced Glycation End-Products Axis.
    Ann Thorac Cardiovasc Surg. 2021 May 19. doi: 10.5761/atcs.oa.21-00027.
    PubMed    
    Abstract available

  106. KUMAR A, Choudhury M, Batra SD, Sikri K, et al
    In vivo assessment of a single adenine mutation in 5'UTR of Endothelin-1 gene in paediatric cases with severe pulmonary hypertension: an observational study.
    BMC Res Notes. 2021;14:194.
    PubMed    
    Abstract available

  107. MORIMOTO Y, Ikeda S, Yamagata Y, Kozu R, et al
    Effect of Living Environment Factors on Quality of Life in Patients With Chronic Thromboembolic Pulmonary Hypertension After Completion of Balloon Pulmonary Angioplasty- A Cross-Sectional Study.
    Circ Rep. 2021;3:279-285.
    PubMed    
    Abstract available


  108. Sharing Progress in Neonatology (SPIN): Oxygen and Surfactant, Optimal Ventilation, Pulmonary Hypertension, Diagnostic Procedures and Definition of Bronchopulmonary Dysplasia.
    Neonatology. 2021;118:252-256.
    PubMed    


  109. AITKEN CR, Stewart G, Walsh J, Seale H, et al
    Assessment of oxygenation after balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension.
    Int J Cardiol. 2021 May 15. pii: S0167-5273(21)00833.
    PubMed    


  110. KEELAN E, Ferguson C, Kerr R
    When common things aren't so common: A case report of hepatopulmonary syndrome.
    Clin Med (Lond). 2021;21:226-227.
    PubMed    
    Abstract available

  111. NINAGAWA K, Kato M, Ohira H, Tsuneta S, et al
    The assessment of left heart disease in patients with systemic sclerosis and pulmonary hypertension.
    Clin Exp Rheumatol. 2021 May 12. pii: 16981.
    PubMed    
    Abstract available

  112. GERGES C, Lang I
    A multiparametric approach for the assessment of prognosis in pulmonary hypertension after pulmonary endarterectomy - stratifying risk in a poorly-defined condition.
    Int J Cardiol. 2021 May 14. pii: S0167-5273(21)00831.
    PubMed    


  113. GALL H, Yogeswaran A, Fuge J, Sommer N, et al
    Validity of echocardiographic tricuspid regurgitation gradient to screen for new definition of pulmonary hypertension.
    EClinicalMedicine. 2021;34:100822.
    PubMed    
    Abstract available

  114. SAGGAR R, Giri PC, Deng C, Johnson D, et al
    Significance of autoimmune disease in severe pulmonary hypertension complicating extensive pulmonary fibrosis: a prospective cohort study.
    Pulm Circ. 2021;11:20458940211011329.
    PubMed    
    Abstract available

  115. KHIRFAN G, Li M, Wang X, DiDonato JA, et al
    Abnormal levels of apolipoprotein A-I in chronic thromboembolic pulmonary hypertension.
    Pulm Circ. 2021;11:20458940211010371.
    PubMed    
    Abstract available

  116. HOBOHM L, Keller K, Munzel T, Konstantinides SV, et al
    Time trends of pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension.
    Pulm Circ. 2021;11:20458940211008069.
    PubMed    
    Abstract available

  117. LI X, Li T
    Inadequate Dosage May Lead to the Recurrence of Postoperative Pulmonary Hypertension in Patients With Congenital Heart Disease.
    Front Pharmacol. 2021;12:660405.
    PubMed    
    Abstract available

  118. PINTALHAO M, Maia-Rocha C, Castro-Chaves P, Adao R, et al
    Urocortin-2 in Acute Heart Failure: Role as a Marker of Volume Overload and Pulmonary Hypertension.
    Curr Probl Cardiol. 2021 Apr 3:100860. doi: 10.1016/j.cpcardiol.2021.100860.
    PubMed    
    Abstract available

  119. GUPTA T, Shariati F, Krim SR
    A Simplified Diagnostic and Therapeutic Approach to Pulmonary Hypertension.
    Curr Probl Cardiol. 2021 Apr 3:100857. doi: 10.1016/j.cpcardiol.2021.100857.
    PubMed    
    Abstract available

  120. ROBLEDO GC, Yamile Jurado Hernandez M, Gomez Gonzales A, Alejandro Gomez Lucas S, et al
    Scimitar Syndrome Associated With Arterial Pulmonary Hypertension. Report a Case and Literature Review.
    Curr Probl Cardiol. 2021 Apr 3:100855. doi: 10.1016/j.cpcardiol.2021.100855.
    PubMed    


  121. ROBLEDO GC, Hernandez MYJ, Lucas SAG, Delgado FRC, et al
    Combined Pulmonary Fibrosis and Emphysema With Pulmonary Hypertension: Cases Report.
    Curr Probl Cardiol. 2021 Apr 15:100856. doi: 10.1016/j.cpcardiol.2021.100856.
    PubMed    
    Abstract available

  122. JACOB S, Pham AN, Sareyyupoglu B, Pham SM, et al
    Bilateral lung transplantation for pulmonary artery aneurysm with severe pulmonary hypertension: An evolution or a revolution?
    J Card Surg. 2021 May 16. doi: 10.1111/jocs.15654.
    PubMed    
    Abstract available

  123. INDOLFI C, Barilla F, Basso C, Ciccone MM, et al
    [Position paper of the Italian Society of Cardiology (SIC) on COVID-19 vaccine priority in patients with cardiovascular diseases].
    G Ital Cardiol (Rome). 2021;22:363-375.
    PubMed    
    Abstract available

  124. SYDYKOV A, Maripov A, Kushubakova N, Muratali Uulu K, et al
    An Exaggerated Rise in Pulmonary Artery Pressure in a High-Altitude Dweller during the Cold Season.
    Int J Environ Res Public Health. 2021;18.
    PubMed    
    Abstract available

  125. LABAZI H, Nilsen M, MacLean MR
    Sex-dependent right ventricular hypertrophic gene changes after methamphetamine treatment in mice.
    Eur J Pharmacol. 2021;900:174066.
    PubMed    
    Abstract available

  126. GONZAGA-COSTA K, Vasconcelos-Silva AA, Rodrigues-Silva MJ, Rebouca CDSM, et al
    Soluble guanylate cyclase stimulator, trans-4-methoxy-beta-nitrostyrene, has a beneficial effect in monocrotaline-induced pulmonary arterial hypertension in rats.
    Eur J Pharmacol. 2021;897:173948.
    PubMed    
    Abstract available

  127. BEIK A, Najafipour H, Joukar S, Rajabi S, et al
    Perillyl alcohol suppresses monocrotaline-induced pulmonary arterial hypertension in rats via anti-remodeling, anti-oxidant, and anti-inflammatory effects.
    Clin Exp Hypertens. 2020 Dec 15:1-11. doi: 10.1080/10641963.2020.1860080.
    PubMed    
    Abstract available

  128. IKOMA T, Suwa K, Sano M, Ushio T, et al
    Early changes of pulmonary arterial hemodynamics in patients with systemic sclerosis: flow pattern, WSS, and OSI analysis with 4D flow MRI.
    Eur Radiol. 2021;31:4253-4263.
    PubMed    
    Abstract available

  129. ZIMMER A, Teixeira RB, Constantin RL, Campos-Carraro C, et al
    The progression of pulmonary arterial hypertension induced by monocrotaline is characterized by lung nitrosative and oxidative stress, and impaired pulmonary artery reactivity.
    Eur J Pharmacol. 2020 Nov 5:173699. doi: 10.1016/j.ejphar.2020.173699.
    PubMed    
    Abstract available

  130. WEI Y, Zhao C, Liang J, Jin Z, et al
    Factors associated with event-free survival in Chinese patients with Takayasu's arteritis.
    Clin Rheumatol. 2021;40:1941-1948.
    PubMed    
    Abstract available

  131. LI S, Ma X, Xie J, Yan X, et al
    MicroRNA-206, IL-4, IL-13, and INF-gamma levels in lung tissue and plasma are increased by the stimulation of particulate matter with a diameter of
    Clin Exp Hypertens. 2020 Oct 21:1-8. doi: 10.1080/10641963.2020.1836192.
    PubMed    
    Abstract available

  132. FOURNEL L, Boudou-Rouquette P, Prieto M, Hervochon R, et al
    Nivolumab increases pulmonary artery pressure in patients treated for non-small cell lung cancer.
    Cancer Chemother Pharmacol. 2020 Sep 16. pii: 10.1007/s00280-020-04142.
    PubMed    
    Abstract available

  133. MIYAHARA S, Schroder TA, Wilkens H, Karliova I, et al
    An Evaluation of the Learning Curve in Pulmonary Endarterectomy Using Propensity Score Matching.
    Thorac Cardiovasc Surg. 2021;69:284-292.
    PubMed    
    Abstract available

  134. BRAGA CL, Felix NS, Teixeira DE, Vieira JB, et al
    Niclosamide attenuates lung vascular remodeling in experimental pulmonary arterial hypertension.
    Eur J Pharmacol. 2020 Aug 11:173438. doi: 10.1016/j.ejphar.2020.173438.
    PubMed    
    Abstract available

  135. ERDEM H, Korun O, Yanartas M, Tas S, et al
    Outcomes of Pulmonary Endarterectomy Operation Concomitant with Cardiac Procedures.
    Thorac Cardiovasc Surg. 2021;69:279-283.
    PubMed    
    Abstract available

  136. SHI Y, Zong Y
    Coexistent Mitral Stenosis and left Circumflex Coronary Artery to left Atrial Fistula in a Patient with Severe Pulmonary Hypertension.
    Braz J Cardiovasc Surg. 2021;36:265-267.
    PubMed    
    Abstract available

  137. KIM HH, Sung SI, Yang MS, Han YS, et al
    Early pulmonary hypertension is a risk factor for bronchopulmonary dysplasia-associated late pulmonary hypertension in extremely preterm infants.
    Sci Rep. 2021;11:11206.
    PubMed    
    Abstract available

  138. PALEVICIUTE E, Gumbiene L, Jureviciene E, Simbelyte T, et al
    The Experience, Prerequisites, and the Barriers in Organizing a Specialized Rehabilitation Program for Patients with Pulmonary Hypertension.
    Respiration. 2021 May 27:1-9. doi: 10.1159/000516331.
    PubMed    
    Abstract available

  139. OAKLAND HT, Joseph P, Naeije R, Elassal A, et al
    The Arterial Load and Right Ventricular-Vascular Coupling in Pulmonary Hypertension.
    J Appl Physiol (1985). 2021 May 27. doi: 10.1152/japplphysiol.00204.2021.
    PubMed    
    Abstract available

  140. KARYOFYLLIS P, Tsiapras D, Demerouti E, Armenis I, et al
    Sickle cell disease related chronic thromboembolic pulmonary hypertension: challenging clinical scenario.
    J Thromb Thrombolysis. 2021 May 27. pii: 10.1007/s11239-021-02483.
    PubMed    
    Abstract available

  141. DASARI P, Gummadi HS
    Pregnancy outcome in Takayasu arteritis.
    BMJ Case Rep. 2021;14.
    PubMed    
    Abstract available

  142. KIM PK, Hong YJ, Shim HS, Im DJ, et al
    Serial T1 mapping of right ventricle in pulmonary hypertension: comparison with histology in an animal study.
    J Cardiovasc Magn Reson. 2021;23:64.
    PubMed    
    Abstract available

  143. SHAH FA, Moronta S, Braford M, Greene N, et al
    Obstructive Sleep Apnea and Pulmonary Hypertension: A Review of Literature.
    Cureus. 2021;13:e14575.
    PubMed    
    Abstract available

  144. ZHANG T, Liang W, Bian L, Wu Z, et al
    Chronic thromboembolic pulmonary hypertension following pulmonary embolism with a right ventricular thrombus: A report of two cases.
    Pulm Circ. 2021;11:20458940211013668.
    PubMed    
    Abstract available

  145. GIRI PC, Stevens GJ, Merrill-Henry J, Oyoyo U, et al
    Participation in pulmonary hypertension support group improves patient-reported health quality outcomes: a patient and caregiver survey.
    Pulm Circ. 2021;11:20458940211013258.
    PubMed    
    Abstract available

  146. ABE K, Kibe R, David K, Reddy V, et al
    Reversible right-sided heart failure and pulmonary hypertension caused by scurvy in a 7-year-old boy with autism spectrum disorder and a review of the literature.
    Paediatr Int Child Health. 2021 May 25:1-5. doi: 10.1080/20469047.2021.1901406.
    PubMed    
    Abstract available

  147. NAKANE T, Esaki J, Ueda R, Honda M, et al
    Inhaled nitric oxide improves pulmonary hypertension and organ functions after adult heart valve surgeries.
    Gen Thorac Cardiovasc Surg. 2021 May 25. pii: 10.1007/s11748-021-01651.
    PubMed    
    Abstract available

  148. LTEIF C, Ataya A, Duarte JD
    Therapeutic Challenges and Emerging Treatment Targets for Pulmonary Hypertension in Left Heart Disease.
    J Am Heart Assoc. 2021 May 25:e020633. doi: 10.1161/JAHA.120.020633.
    PubMed    
    Abstract available

  149. BITNERS AC, Arens R, Mahgerefteh J, Sutton NJ, et al
    Prevalence of elevated right ventricular pressure in children with obstructive sleep apnea syndrome undergoing pulmonary hypertension screening.
    J Clin Sleep Med. 2021 May 24. doi: 10.5664/jcsm.9412.
    PubMed    
    Abstract available

  150. VIJAYARAGHAVAN M, Prins KW, Prisco SZ, Duval S, et al
    Hemodynamic Characteristics and Outcomes of Pulmonary Hypertension in Patients Undergoing Tricuspid Valve Repair or Replacement.
    CJC Open. 2020;3:488-497.
    PubMed    
    Abstract available

  151. HUSTON JH, Maron BA
    Adjusting to the New Normal: Echocardiography to Find Pulmonary Hypertension.
    EClinicalMedicine. 2021;35:100867.
    PubMed    


  152. SHAO Y, Yin X, Qin T, Zhang R, et al
    Prevalence and Associated Factors of Portopulmonary Hypertension in Patients with Portal Hypertension: A Case-Control Study.
    Biomed Res Int. 2021;2021:5595614.
    PubMed    
    Abstract available

  153. ZENG Y, Li N, Zheng Z, Chen R, et al
    Screening of Hub Genes Associated with Pulmonary Arterial Hypertension by Integrated Bioinformatic Analysis.
    Biomed Res Int. 2021;2021:6626094.
    PubMed    
    Abstract available

  154. MIOTTI C, Papa S, Manzi G, Luongo F, et al
    Incidence and long-term outcomes of pregnant women complicated with pulmonary arterial hypertension during different pregnancies: A prospective cohort study from China.
    Int J Cardiol. 2021;332:193-194.
    PubMed    


  155. BENZA RL, Farber HW, Frost AE, Ghofrani HA, et al
    Application of the REVEAL risk score calculator 2.0 in the PATENT study.
    Int J Cardiol. 2021;332:189-192.
    PubMed    
    Abstract available

  156. ALENEZI F, Rajagopal S
    The right atrium, more than a storehouse.
    Int J Cardiol. 2021;331:329-330.
    PubMed    


  157. MESSINA CMS, Ferreira EVM, Singh I, Fonseca AXC, et al
    Impact of right ventricular work and pulmonary arterial compliance on peak exercise oxygen uptake in idiopathic pulmonary arterial hypertension.
    Int J Cardiol. 2021;331:230-235.
    PubMed    
    Abstract available

  158. LASHKARINIA SS, Coban G, Kose B, Salihoglu E, et al
    Computational modeling of vascular growth in patient-specific pulmonary arterial patch reconstructions.
    J Biomech. 2021;117:110274.
    PubMed    
    Abstract available

  159. KHANNA D, Zhao C, Saggar R, Mathai SC, et al
    Long-Term Outcomes in Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension in the Modern Treatment Era: Meta-Analyses of Randomized, Controlled Trials and Observational Registries.
    Arthritis Rheumatol. 2021;73:837-847.
    PubMed    
    Abstract available

  160. SUN D, Yang W, Wang Z, Gao B, et al
    Efficacy of Beraprost Sodium Combined with Sildenafil and Its Effects on Vascular Endothelial Function and Inflammation in Patients Experiencing Left Heart Failure Complicated with Pulmonary Arterial Hypertension.
    Med Sci Monit. 2021;27:e928413.
    PubMed    
    Abstract available

  161. SPIESSHOEFER J, Gentile F, Borrelli C, Giannoni A, et al
    Use of hypocapnia for improved risk stratification in pulmonary arterial hypertension: should we return to respiratory pathophysiology?
    Int J Cardiol. 2021;329:208.
    PubMed    


  162. LOW TT, Granton J
    Pregnant with pulmonary arterial hypertension - Can we handle the pressure?
    Int J Cardiol. 2021;328:180-181.
    PubMed    


  163. KANG SL, Contreras J, Chaturvedi RR
    Transcatheter creation of a Potts shunt with the Occlutech Atrial Flow Regulator: Feasibility in a pig model.
    Int J Cardiol. 2021;327:63-65.
    PubMed    
    Abstract available

  164. YANG M, Wang J, Zhang X, Zhuang Q, et al
    Incidence and long-term outcomes of pregnant women complicated with pulmonary arterial hypertension during different pregnancies: A prospective cohort study from China.
    Int J Cardiol. 2021;326:178-183.
    PubMed    
    Abstract available

  165. AULAK KS, Al Abdi S, Li L, Crabb JS, et al
    Disease-specific platelet signaling defects in idiopathic pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2021;320:L739-L749.
    PubMed    
    Abstract available

  166. WOODCOCK CC, Hafeez N, Handen A, Tang Y, et al
    Matrix stiffening induces a pathogenic QKI-miR-7-SRSF1 signaling axis in pulmonary arterial endothelial cells.
    Am J Physiol Lung Cell Mol Physiol. 2021;320:L726-L738.
    PubMed    
    Abstract available

  167. HONG J, Arneson D, Umar S, Ruffenach G, et al
    Single-Cell Study of Two Rat Models of Pulmonary Arterial Hypertension Reveals Connections to Human Pathobiology and Drug Repositioning.
    Am J Respir Crit Care Med. 2021;203:1006-1022.
    PubMed    
    Abstract available

  168. MIYAHARA S, Schroder TA, Wilkens H, Karliova I, et al
    Long-term Outcomes After Pulmonary Endarterectomy in 499 Patients Over a 20-Year Period.
    Ann Thorac Surg. 2021;111:1585-1592.
    PubMed    
    Abstract available

  169. SIMPSON CE, Damico RL, Hassoun PM, Martin LJ, et al
    Noninvasive prognostic biomarkers for left heart failure as predictors of survival in pulmonary arterial hypertension.
    Chest. 2020 Jan 24. pii: S0012-3692(20)30129-X. doi: 10.1016/j.chest.2019.
    PubMed    
    Abstract available

  170. TRAMMELL AW, Hart CM
    Identifying New Targets for Treatment of Pulmonary Hypertension.
    Chest. 2021;159:1326-1327.
    PubMed    


  171. BRIDA M, Nashat H, Gatzoulis MA
    Pulmonary arterial hypertension: closing the gap in congenital heart disease.
    Curr Opin Pulm Med. 2020 Jul 9. doi: 10.1097/MCP.0000000000000695.
    PubMed    
    Abstract available

  172. PASRIJA D, Gupta S, Breuer R, Herendeen J, et al
    Pulmonary Veno Occlusive Disease Presenting as Failure to Thrive.
    Indian J Pediatr. 2021;88:494.
    PubMed    


  173. STOMBAUGH DK, Thomas C, Dalton A, Chaney MA, et al
    Pheochromocytoma Resection in a Patient With Chronic Thromboembolic Pulmonary Hypertension and Thrombocytopenia.
    J Cardiothorac Vasc Anesth. 2021 Mar 26. pii: S1053-0770(21)00276.
    PubMed    


  174. KOTHARI P, Nguyen QS, Pagel PS, Choi C, et al
    Gradually Progressive Dyspnea and Exercise Intolerance in an Otherwise Active Middle-Aged Woman: Why Was the Presentation of Congenital Heart Disease Delayed?
    J Cardiothorac Vasc Anesth. 2021;35:1225-1230.
    PubMed    
    Abstract available

  175. GELZINIS TA
    The Effect of Pulmonary Disease on the Intraoperative Management of Lung Transplant Patients.
    J Cardiothorac Vasc Anesth. 2021;35:539-541.
    PubMed    


  176. MCMAHON A, McNamara J, Griffin M
    A Review of Heart Transplantation for Adults With Congenital Heart Disease.
    J Cardiothorac Vasc Anesth. 2021;35:752-762.
    PubMed    
    Abstract available

  177. BOHMAN JK, Findlay JY, Krowka MJ
    ECMO and POPH: More Help for the Right Heart.
    Liver Transpl. 2021;27:627-628.
    PubMed    


  178. NATHAN SD, Waxman A, Tapson V
    Inhaled Treprostinil in Group 3 Pulmonary Hypertension. Reply.
    N Engl J Med. 2021;384:1871-1872.
    PubMed    


  179. AVDEEV S, Tsareva N, Nekludova G
    Inhaled Treprostinil in Group 3 Pulmonary Hypertension.
    N Engl J Med. 2021;384:1871.
    PubMed    


  180. MORAN-MENDOZA O, Min B, Neder JA
    Inhaled Treprostinil in Group 3 Pulmonary Hypertension.
    N Engl J Med. 2021;384:1870-1871.
    PubMed    


  181. SAGGAR R, Abtin F, Channick R
    Inhaled Treprostinil in Group 3 Pulmonary Hypertension.
    N Engl J Med. 2021;384:1870.
    PubMed    


  182. SOTO FJ, Kravitz JN, Dhand R
    Inhaled Treprostinil in Group 3 Pulmonary Hypertension.
    N Engl J Med. 2021;384:1869-1870.
    PubMed    


  183. NASSER M, Kolb M, Cottin V
    Inhaled Treprostinil in Group 3 Pulmonary Hypertension.
    N Engl J Med. 2021;384:1869.
    PubMed    


  184. RUBIN EJ, Baden LR, Drazen JM, Taichman DB, et al
    Audio Interview: Vaccination in Nursing Homes and New Pulmonary/Critical Care Research.
    N Engl J Med. 2021;384:e89.
    PubMed    



Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;